Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-2 | 127.5 | 50 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MMP-2 | 129.5 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-2 | 305.5 | 50 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MMP-2 | 414.0 | 53 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 85.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 169.5 | 54 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 92.5 | 50 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 113.0 | 56 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 179.0 | 37 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 341.0 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 121.0 | 41 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MMP-2 | 176.5 | 54 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 162.0 | 50 | |
N2645 | TNF-a | 100 | ng/mL | 4 | MMP-2 | 118.5 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-2 | 286.5 | 50 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | MMP-2 | 408.0 | 47 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MMP-2 | 90.0 | 50 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MMP-2 | 109.0 | 50 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MMP-2 | 78.0 | 50 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | MMP-2 | 172.5 | 54 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MMP-2 | 269.5 | 34 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | MMP-2 | 275.5 | 50 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | MMP-2 | 138.5 | 50 | ||||
RA2159 | 4 | MMP-2 | 98.5 | 56 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | MMP-2 | 138.0 | 50 |